Italy's Chiesi Group has revealed plans to spend €430 million ($464 million) on a new therapeutics manufacturing facility at ...

A shuttered Milanese manufacturing site with a storied history is getting a new lease on life, thanks to a nearly ...

Italian biopharma Chiesi Group has announced a major investment in Nerviano, near Milan, with the building of a new facility ...

In-house drug development of biologicals and rare disease targeting In brief, the European plan for Chiesi is in-house drug development of biologicals and rare disease targeting. The Parma site ...